Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by van Lieshout, E. M.
Right arrow Articles by Peters, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Lieshout, E. M.
Right arrow Articles by Peters, W. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 2055-2057, Copyright © 1998 by Oxford University Press


ARTICLES

Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta 1-1 levels

EM van Lieshout, MM Bedaf, M Pieter, C Ekkel, WA Nijhoff and WH Peters
Department of Gastroenterology, St Radboud University Hospital, Nijmegen, The Netherlands.

Several naturally occurring food components or non-steroidal anti- inflammatory drugs (NSAIDs) may reduce gastrointestinal cancer rates. Recently we have shown that dietary administration of such compounds enhanced the glutathione S-transferase (GST) enzyme activity and class alpha, mu and pi isoenzyme levels in the rat gastrointestinal tract. Elevation of the levels of GSTs, a family of biotransformation enzymes with many functions such as detoxification of carcinogens, might be one of the mechanisms that lead to cancer prevention. We therefore investigated whether the anticarcinogens alpha-angelicalactone, alpha- tocopherol, beta-carotene, coumarin, ellagic acid, flavone, indole-3- carbinol, d-limonene, oltipraz, phenethylisothiocyanate (PEITC) and the sulphoraphane analogue compound-30 affect gastrointestinal rGSTT1-1 protein levels in male Wistar rats. rGSTT1-1 protein levels were determined in cytosolic fractions of liver and oesophageal-, gastric-, small intestinal- and colonic mucosa by densitometrical analyses of western blots after immunodetection with an anti human GSTT1-1 monoclonal antibody, that cross-reacts with rGSTT1-1. In control Wistar rats, gastrointestinal rGSTT1-1 protein levels were highest in the liver and decreased in the order liver > stomach > colon > oesophagus > small intestine. Gastric rGSTT1-1 protein levels were enhanced by alpha- angelicalactone, alpha-tocopherol, coumarin, ellagic acid, oltipraz, PEITC and the sulphoraphane analogue compound-30. Oesophageal rGSTT1-1 protein levels were elevated by a-angelicalactone and coumarin, whereas colonic rGSTT1-1 protein levels were elevated by coumarin. Ellagic acid, on the other hand, reduced hepatic rGSTT1-1 protein levels to 53% of the control. In conclusion, dietary anticarcinogens are capable of inducing rGSTT1-1 protein levels in the rat gastrointestinal tract, and are most pronounced in the stomach. Enhanced rGSTT1-1 protein levels might lead to an increase of enzyme activity and to a more efficient detoxification of carcinogens and thus could contribute to prevention of carcinogenesis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
R. Munday and C. M. Munday
Induction of phase II enzymes by 3H-1,2-dithiole-3-thione: dose-response study in rats
Carcinogenesis, September 1, 2004; 25(9): 1721 - 1725.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
L. S. Kaminsky and Q.-Y. Zhang
THE SMALL INTESTINE AS A XENOBIOTIC-METABOLIZING ORGAN
Drug Metab. Dispos., December 1, 2003; 31(12): 1520 - 1525.
[Full Text] [PDF]


Home page
J. Nutr.Home page
S. U. Mertens-Talcott, S. T. Talcott, and S. S. Percival
Low Concentrations of Quercetin and Ellagic Acid Synergistically Influence Proliferation, Cytotoxicity and Apoptosis in MOLT-4 Human Leukemia Cells-
J. Nutr., August 1, 2003; 133(8): 2669 - 2674.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
N. Petri, C. Tannergren, B. Holst, F. A. Mellon, Y. Bao, G. W. Plumb, J. Bacon, K. A. O'Leary, P. A. Kroon, L. Knutson, et al.
ABSORPTION/METABOLISM OF SULFORAPHANE AND QUERCETIN, AND REGULATION OF PHASE II ENZYMES, IN HUMAN JEJUNUM IN VIVO
Drug Metab. Dispos., June 1, 2003; 31(6): 805 - 813.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. Stoner, B. Casto, S. Ralston, B. Roebuck, C. Pereira, and G. Bailey
Development of a multi-organ rat model for evaluating chemopreventive agents: efficacy of indole-3-carbinol
Carcinogenesis, February 1, 2002; 23(2): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
W.C.C. de Bruin, M.J.M. Wagenmans, P.G. Board, and W.H.M. Peters
Expression of glutathione S-transferase {theta} class isoenzymes in human colorectal and gastric cancers
Carcinogenesis, August 1, 1999; 20(8): 1453 - 1458.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.